Nektar Therapeutics | NKTR - Trade Debtors


Nektar Therapeutics reported $3.6M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
ALKERMES USD 456.48M 48.85M Jun/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Amgen USD 10.23B 1.09B Jun/2026
Baxter International USD 1.86B 158M Jun/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 62.19B 12.42B Mar/2026
Dr.Reddys Laboratories INR 124.42B 19.68B Jun/2026
Eisai JPY 253.13B 26.12B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Exelixis USD 322.21M 6.73M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merck USD 12.21B 435M Mar/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 887M 118.9M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Takeda JPY 956.14B 79.79B Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026
Xencor USD 42.23M 30.23M Jun/2026